Skip to content
Clinical Trials – home

Ketamine: A Versatile Medication for Pain and Mental Health

13 / 13
trials open to patients / all trials
9+
Countries

In short

This article examines the use of ketamine in various clinical trials, focusing on its potential applications in pain management, anesthesia, and treatment of depression. Ketamine, a versatile drug with both anesthetic and analgesic properties, is being studied in different forms and dosages to evaluate its efficacy and safety in treating conditions such as complex regional pain syndrome, postoperative pain, and major depressive disorder.

At a glance

Forms of Ketamine
Intravenous, intranasal (Spravato), oral tablets, combined anesthesia
Conditions Studied
Complex regional pain syndrome, major depressive disorder, postoperative pain, anesthesia for surgery
Key Outcomes Measured
Pain scores, depression severity, patient satisfaction, pharmacokinetics, safety and tolerability
Potential Benefits
Pain reduction, improved anesthesia, rapid relief of depressive symptoms, reduced opioid consumption
Safety Considerations
Monitoring for dose-limiting toxicities, determining maximum tolerated dose, assessing adverse events
Special Populations
Postpartum women, patients undergoing cesarean delivery, individuals with treatment-resistant depression

What is Ketamine?

Ketamine is a medication that has been used since the 1970s. It was originally developed as an anesthetic, which is a drug used to put people to sleep for surgery. However, in recent years, doctors have found that ketamine can be helpful for treating other conditions as well, particularly certain types of pain and mental health issues.

Ketamine works by affecting a receptor in the brain called the N-methyl-D-aspartate (NMDA) receptor. This receptor is involved in pain signaling and mood regulation. By blocking this receptor, ketamine can help reduce pain and improve mood in some people.

There are two forms of ketamine:

  • Racemic ketamine: This is the standard form that contains two mirror-image molecules (called stereoisomers).
  • S-ketamine (also called esketamine): This contains only one of the two stereoisomers and is considered to be more potent.

Uses of Ketamine

Ketamine is being studied and used for several medical purposes:

  1. Chronic Pain: Ketamine is being investigated for treating various chronic pain conditions, including:
    • Complex Regional Pain Syndrome (CRPS): A condition that causes severe, long-lasting pain, usually in an arm or leg.
    • Fibromyalgia: A disorder characterized by widespread muscle pain and tenderness.
    • Neuropathic pain: Pain caused by damage or disease affecting the nervous system.
  2. Acute Pain: Ketamine is being studied for managing short-term pain, such as:
    • Pain in the emergency department.
    • Post-operative pain (pain after surgery).
  3. Mental Health Conditions: While not explicitly mentioned in the provided trials, ketamine is known to be used for treating depression and other mental health disorders.
  4. Anesthesia: Ketamine continues to be used as an anesthetic, especially for short procedures or in combination with other medications.

How Ketamine is Administered

Ketamine can be given in several ways, depending on the condition being treated and the specific situation:

  • Intravenous (IV): Given directly into a vein. This is common for pain management and anesthesia.
  • Intramuscular (IM): Injected into a muscle.
  • Intranasal: Sprayed into the nose. This method is being studied for sedation in children.
  • Mesotherapy: A technique where very small doses are injected just under the skin.

The dose and frequency of ketamine administration can vary widely depending on the condition being treated and the individual patient's needs.

Effectiveness of Ketamine

Research suggests that ketamine may be effective for several conditions:

  • Chronic Pain: Some studies have shown that ketamine can provide significant pain relief for conditions like CRPS and fibromyalgia.
  • Acute Pain: Ketamine may help reduce pain and the need for other pain medications in emergency situations and after surgery.
  • Anesthesia: Ketamine is effective as an anesthetic, especially when combined with other medications.

However, it's important to note that the effectiveness can vary from person to person, and more research is needed to fully understand how well ketamine works for different conditions.

Side Effects and Safety

Like all medications, ketamine can cause side effects. Some potential side effects include:

  • Dizziness or feeling lightheaded
  • Nausea or vomiting
  • Changes in vision or hearing
  • Feelings of unreality or dissociation (feeling disconnected from your body or surroundings)
  • Changes in blood pressure or heart rate
  • In rare cases, more serious side effects can occur

Ketamine is generally considered safe when used under medical supervision. However, it's not suitable for everyone. People with certain medical conditions or who are taking certain medications may not be able to use ketamine safely.

Ongoing Research

Scientists are continuing to study ketamine to better understand how it works and how it might be used to help people. Some areas of ongoing research include:

  • Using ketamine for different types of pain conditions
  • Comparing different doses and methods of giving ketamine
  • Studying how ketamine affects decision-making and cognitive processes
  • Investigating the long-term effects of ketamine use

As research continues, we may discover new ways that ketamine can help people with various medical conditions.

Questions people often ask

Conditions where Ketamine is being studied

Each condition opens its own overview and trial list

Trials with Ketamine

Recruiting trials first

See all 13 →
Quick filters
  • Participants:Children
  • Participants:Adults
  • Participants:Adults
  • Participants:Children
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).